Literature DB >> 35809158

Kinetics of the humoral response 1-year following vaccination with BNT162b2 SARS-CoV-2 vaccine among maintenance hemodialysis patients.

Ori Wand1,2,3, Yael Einbinder4,5, Naomi Nacasch4,5, Tamar Halperin4,6, Daniel Erez4,7, Ayelet Grupper4,8, Sydney Benchetrit4,5, Michael Lishner4,9, Amir Bar-Shai10,4,11, Moshe Shashar12, Keren Cohen-Hagai4,5.   

Abstract

Entities:  

Keywords:  Anti-spike antibodies; COVID-19; Delta variant; Hemodialysis; SARS-CoV-2

Year:  2022        PMID： 35809158     DOI： 10.1007/s40620-022-01377-y

Source DB:  PubMed          Journal:  J Nephrol        ISSN： 1121-8428            Impact factor:   3.902


× No keyword cloud information.
  6 in total

1.  Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients.

Authors:  Moshe Shashar; Naomi Nacasch; Ayelet Grupper; Sydney Benchetrit; Tamar Halperin; Daniel Erez; Ilan Rozenberg; Pnina Shitrit; Yaron Sela; Ori Wand; Keren Cohen-Hagai
Journal:  Am J Nephrol       Date:  2022-02-16       Impact factor: 4.605

2.  SARS-CoV-2 Vaccine Antibody Response and Breakthrough Infection in Patients Receiving Dialysis.

Authors:  Shuchi Anand; Maria E Montez-Rath; Jialin Han; Pablo Garcia; LinaCel Cadden; Patti Hunsader; Curt Morgan; Russell Kerschmann; Paul Beyer; Mary Dittrich; Geoffrey A Block; Glenn M Chertow; Julie Parsonnet
Journal:  Ann Intern Med       Date:  2021-12-14       Impact factor: 51.598

3.  mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant.

Authors:  Wilfredo F Garcia-Beltran; Kerri J St Denis; Angelique Hoelzemer; Evan C Lam; Adam D Nitido; Maegan L Sheehan; Cristhian Berrios; Onosereme Ofoman; Christina C Chang; Blake M Hauser; Jared Feldman; Alex L Roederer; David J Gregory; Mark C Poznansky; Aaron G Schmidt; A John Iafrate; Vivek Naranbhai; Alejandro B Balazs
Journal:  Cell       Date:  2022-01-06       Impact factor: 41.582

4.  A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis.

Authors:  Maxime Espi; Xavier Charmetant; Thomas Barba; Cyrille Mathieu; Caroline Pelletier; Laetitia Koppe; Elodie Chalencon; Emilie Kalbacher; Virginie Mathias; Anne Ovize; Emmanuelle Cart-Tanneur; Christine Bouz; Laurence Pellegrina; Emmanuel Morelon; Laurent Juillard; Denis Fouque; Cécile Couchoud; Olivier Thaunat
Journal:  Kidney Int       Date:  2021-11-29       Impact factor: 10.612

5.  Waning but persistent humoral response 6 months after the third dose of the mRNA BNT162b2 vaccine in hemodialysis and peritoneal dialysis patients.

Authors:  Pierre Housset; Sabah Kubab; Agathe Pardon; Nathalie Vittoz; Dogan-Firat Bozman; Latifa Hanafi; Valérie Caudwell; Anne-Laure Faucon
Journal:  J Nephrol       Date:  2022-02-22       Impact factor: 4.393

Review 6.  SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact.

Authors:  Marc Lipsitch; Florian Krammer; Gili Regev-Yochay; Yaniv Lustig; Ran D Balicer
Journal:  Nat Rev Immunol       Date:  2021-12-07       Impact factor: 53.106
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.